# Belden Inc.: financial statements, quarterly

BDC · NYSE · CIK 913142 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bdc.md) · [Financials](/companies/bdc/financials.md) · [Filings](/companies/bdc/filings.md) · [Insiders](/companies/bdc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bdc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [551 d](/filings/0000913142-26-000009.md) | [536](/filings/0000913142-25-000013.md) | [604](/filings/0000913142-25-000024.md) | [655](/filings/0000913142-25-000033.md) | [666 d](/filings/0000913142-26-000009.md) | [625](/filings/0000913142-26-000023.md) | [672](/filings/0000913142-26-000034.md) | [698](/filings/0000913142-26-000042.md) | [720 d](/filings/0000913142-26-000009.md) | [696](/filings/0000913142-26-000023.md) | [750](/filings/0000913142-26-000034.md) | [966](/filings/0000913142-26-000042.md) |
| Cost of revenue | $m | [345 d](/filings/0000913142-26-000009.md) | [334](/filings/0000913142-25-000013.md) | [378](/filings/0000913142-25-000024.md) | [411](/filings/0000913142-25-000033.md) | [416 d](/filings/0000913142-26-000009.md) | [379](/filings/0000913142-26-000023.md) | [413](/filings/0000913142-26-000034.md) | [435](/filings/0000913142-26-000042.md) | [457 d](/filings/0000913142-26-000009.md) | [438](/filings/0000913142-26-000023.md) | [457](/filings/0000913142-26-000034.md) | [627](/filings/0000913142-26-000042.md) |
| Gross profit | $m | [206 d](/filings/0000913142-26-000009.md) | [202](/filings/0000913142-25-000013.md) | [227](/filings/0000913142-25-000024.md) | [244](/filings/0000913142-25-000033.md) | [250 d](/filings/0000913142-26-000009.md) | [246](/filings/0000913142-26-000023.md) | [259](/filings/0000913142-26-000034.md) | [263](/filings/0000913142-26-000042.md) | [264 d](/filings/0000913142-26-000009.md) | [258](/filings/0000913142-26-000023.md) | [294](/filings/0000913142-26-000034.md) | [339](/filings/0000913142-26-000042.md) |
| Research and development | $m | [25.9 d](/filings/0000913142-26-000009.md) | [27.0](/filings/0000913142-25-000013.md) | [28.5](/filings/0000913142-25-000024.md) | [27.9](/filings/0000913142-25-000033.md) | [29.0 d](/filings/0000913142-26-000009.md) | [28.4](/filings/0000913142-26-000023.md) | [33.9](/filings/0000913142-26-000034.md) | [33.9](/filings/0000913142-26-000042.md) | [32.5 d](/filings/0000913142-26-000009.md) | [30.1](/filings/0000913142-26-000023.md) | [31.7](/filings/0000913142-26-000034.md) | [55.2](/filings/0000913142-26-000042.md) |
| Selling, general and administrative | $m | [126 d](/filings/0000913142-26-000009.md) | [111](/filings/0000913142-25-000013.md) | [119](/filings/0000913142-25-000024.md) | [127](/filings/0000913142-25-000033.md) | [137 d](/filings/0000913142-26-000009.md) | [132](/filings/0000913142-26-000023.md) | [132](/filings/0000913142-26-000034.md) | [139](/filings/0000913142-26-000042.md) | [131 d](/filings/0000913142-26-000009.md) | [139](/filings/0000913142-26-000023.md) | [148](/filings/0000913142-26-000034.md) | [212](/filings/0000913142-26-000042.md) |
| Operating income | $m | [44.0 d](/filings/0000913142-26-000009.md) | [53.0](/filings/0000913142-25-000013.md) | [68.9](/filings/0000913142-25-000024.md) | [75.3](/filings/0000913142-25-000033.md) | [69.2 d](/filings/0000913142-26-000009.md) | [72.6](/filings/0000913142-26-000023.md) | [79.2](/filings/0000913142-26-000034.md) | [76.3](/filings/0000913142-26-000042.md) | [87.5 d](/filings/0000913142-26-000009.md) | [78.0](/filings/0000913142-26-000023.md) | [99.3](/filings/0000913142-26-000034.md) | [16.8](/filings/0000913142-26-000042.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(2.2) d](/filings/0000913142-26-000009.md) | [8.4](/filings/0000913142-25-000013.md) | [11.1](/filings/0000913142-25-000024.md) | [11.1](/filings/0000913142-25-000033.md) | [(1.0) d](/filings/0000913142-26-000009.md) | [10.1](/filings/0000913142-26-000023.md) | [5.7](/filings/0000913142-26-000034.md) | [7.6](/filings/0000913142-26-000042.md) | [6.0 d](/filings/0000913142-26-000009.md) | [11.7](/filings/0000913142-26-000023.md) | [16.7](/filings/0000913142-26-000034.md) | [(14.2)](/filings/0000913142-26-000042.md) |
| Net income | $m | [38.5 d](/filings/0000913142-26-000009.md) | [37.3](/filings/0000913142-25-000013.md) | [49.0](/filings/0000913142-25-000024.md) | [53.7](/filings/0000913142-25-000033.md) | [58.4 d](/filings/0000913142-26-000009.md) | [51.9](/filings/0000913142-26-000042.md) | [61.0](/filings/0000913142-26-000042.md) | [56.7](/filings/0000913142-26-000042.md) | [67.9 d](/filings/0000913142-26-000009.md) | [51.0](/filings/0000913142-26-000042.md) | [68.5](/filings/0000913142-26-000042.md) | [(11.4)](/filings/0000913142-26-000042.md) |
| Diluted EPS | $ per share | not reported | [0.90](/filings/0000913142-25-000013.md) | [1.19](/filings/0000913142-25-000024.md) | [1.30](/filings/0000913142-25-000033.md) | not reported | [1.27](/filings/0000913142-26-000023.md) | [1.53](/filings/0000913142-26-000034.md) | [1.41](/filings/0000913142-26-000042.md) | not reported | [1.30](/filings/0000913142-26-000023.md) | [1.74](/filings/0000913142-26-000034.md) | [(0.29)](/filings/0000913142-26-000042.md) |
| Basic EPS | $ per share | not reported | [0.91](/filings/0000913142-25-000013.md) | [1.21](/filings/0000913142-25-000024.md) | [1.32](/filings/0000913142-25-000033.md) | not reported | [1.29](/filings/0000913142-26-000023.md) | [1.54](/filings/0000913142-26-000034.md) | [1.43](/filings/0000913142-26-000042.md) | not reported | [1.31](/filings/0000913142-26-000023.md) | [1.76](/filings/0000913142-26-000034.md) | [(0.29)](/filings/0000913142-26-000042.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [597](/filings/0000913142-26-000009.md) | [507](/filings/0000913142-24-000018.md) | [565](/filings/0000913142-24-000029.md) | [323](/filings/0000913142-24-000039.md) | [370](/filings/0000913142-26-000009.md) | [259](/filings/0000913142-25-000013.md) | [301](/filings/0000913142-25-000024.md) | [314](/filings/0000913142-25-000033.md) | [390](/filings/0000913142-26-000042.md) | [272](/filings/0000913142-26-000023.md) | [349](/filings/0000913142-26-000034.md) | [381](/filings/0000913142-26-000042.md) |
| Current assets | $m | [1,457](/filings/0000913142-25-000005.md) | [1,314](/filings/0000913142-24-000018.md) | [1,413](/filings/0000913142-24-000029.md) | [1,198](/filings/0000913142-24-000039.md) | [1,196](/filings/0000913142-26-000009.md) | [1,133](/filings/0000913142-25-000013.md) | [1,223](/filings/0000913142-25-000024.md) | [1,259](/filings/0000913142-25-000033.md) | [1,349](/filings/0000913142-26-000042.md) | [1,280](/filings/0000913142-26-000023.md) | [1,394](/filings/0000913142-26-000034.md) | [1,734](/filings/0000913142-26-000042.md) |
| Total assets | $m | [3,240](/filings/0000913142-26-000009.md) | [3,119](/filings/0000913142-24-000018.md) | [3,523](/filings/0000913142-24-000029.md) | [3,340](/filings/0000913142-24-000039.md) | [3,328](/filings/0000913142-26-000009.md) | [3,271](/filings/0000913142-25-000013.md) | [3,400](/filings/0000913142-25-000024.md) | [3,437](/filings/0000913142-25-000033.md) | [3,544](/filings/0000913142-26-000042.md) | [3,459](/filings/0000913142-26-000023.md) | [3,567](/filings/0000913142-26-000034.md) | [5,967](/filings/0000913142-26-000042.md) |
| Current liabilities | $m | [634](/filings/0000913142-25-000005.md) | [515](/filings/0000913142-24-000018.md) | [830](/filings/0000913142-24-000029.md) | [579](/filings/0000913142-24-000039.md) | [623](/filings/0000913142-26-000009.md) | [588](/filings/0000913142-25-000013.md) | [616](/filings/0000913142-25-000024.md) | [631](/filings/0000913142-25-000033.md) | [697](/filings/0000913142-26-000042.md) | [614](/filings/0000913142-26-000023.md) | [653](/filings/0000913142-26-000034.md) | [951](/filings/0000913142-26-000042.md) |
| Long-term debt | $m | [1,204](/filings/0000913142-25-000005.md) | [1,180](/filings/0000913142-24-000018.md) | [1,165](/filings/0000913142-24-000029.md) | [1,219](/filings/0000913142-24-000039.md) | [1,130](/filings/0000913142-26-000009.md) | [1,179](/filings/0000913142-25-000013.md) | [1,271](/filings/0000913142-25-000024.md) | [1,284](/filings/0000913142-25-000033.md) | [1,286](/filings/0000913142-26-000042.md) | [1,260](/filings/0000913142-26-000023.md) | [1,231](/filings/0000913142-26-000034.md) | [3,032](/filings/0000913142-26-000042.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000913142-26-000042.md) | not reported | not reported | [18.5](/filings/0000913142-26-000042.md) |
| Shareholders' equity | $m | [1,166](/filings/0000913142-25-000005.md) | [1,156](/filings/0000913142-24-000018.md) | [1,220](/filings/0000913142-24-000029.md) | [1,235](/filings/0000913142-24-000039.md) | [1,295](/filings/0000913142-26-000042.md) | [1,223](/filings/0000913142-26-000042.md) | [1,234](/filings/0000913142-26-000042.md) | [1,242](/filings/0000913142-26-000042.md) | [1,264](/filings/0000913142-26-000042.md) | [1,283](/filings/0000913142-26-000042.md) | [1,385](/filings/0000913142-26-000042.md) | [1,392](/filings/0000913142-26-000042.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [160 d](/filings/0000913142-26-000009.md) | [2.7](/filings/0000913142-25-000013.md) | [83.0 d](/filings/0000913142-25-000024.md) | [91.7 d](/filings/0000913142-25-000033.md) | [175 d](/filings/0000913142-26-000009.md) | [7.4](/filings/0000913142-26-000023.md) | [82.0 d](/filings/0000913142-26-000034.md) | [105 d](/filings/0000913142-26-000042.md) | [160 d](/filings/0000913142-26-000009.md) | [(18.7)](/filings/0000913142-26-000023.md) | [129 d](/filings/0000913142-26-000034.md) | [130 d](/filings/0000913142-26-000042.md) |
| Capital expenditure | $m | [54.9 d](/filings/0000913142-26-000009.md) | [24.3](/filings/0000913142-25-000013.md) | [22.0 d](/filings/0000913142-25-000024.md) | [24.5 d](/filings/0000913142-25-000033.md) | [58.3 d](/filings/0000913142-26-000009.md) | [32.2](/filings/0000913142-26-000023.md) | [25.2 d](/filings/0000913142-26-000034.md) | [39.7 d](/filings/0000913142-26-000042.md) | [39.1 d](/filings/0000913142-26-000009.md) | [44.4](/filings/0000913142-26-000023.md) | [40.7 d](/filings/0000913142-26-000034.md) | [47.8 d](/filings/0000913142-26-000042.md) |
| Dividends paid | $m | [2.1 d](/filings/0000913142-26-000009.md) | [2.1](/filings/0000913142-25-000013.md) | [2.0 d](/filings/0000913142-25-000024.md) | [2.0 d](/filings/0000913142-25-000033.md) | [2.0 d](/filings/0000913142-26-000009.md) | [2.0](/filings/0000913142-26-000023.md) | [2.0 d](/filings/0000913142-26-000034.md) | [2.0 d](/filings/0000913142-26-000042.md) | [2.0 d](/filings/0000913142-26-000009.md) | [2.0](/filings/0000913142-26-000023.md) | [2.0 d](/filings/0000913142-26-000034.md) | [1.9 d](/filings/0000913142-26-000042.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [43.7](/filings/0000913142-24-000018.md) | [43.1](/filings/0000913142-24-000029.md) | [42.6](/filings/0000913142-24-000039.md) | [41.5](/filings/0000913142-25-000013.md) | [41.2](/filings/0000913142-25-000024.md) | [41.4](/filings/0000913142-25-000033.md) | [40.8](/filings/0000913142-26-000023.md) | [40.0](/filings/0000913142-26-000034.md) | [40.1](/filings/0000913142-26-000042.md) | [39.4](/filings/0000913142-26-000023.md) | [39.3](/filings/0000913142-26-000034.md) | [39.1](/filings/0000913142-26-000042.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 39,100,023 at 2026-10-22, from the cover of the [10-Q filed 2026-10-29](/filings/0000913142-26-000042.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 14:50 ET. No prices; not investment advice.